Fan He, PhD

Research Program Hematopoietic Development & Malignancy
Researcher placeholder

Researcher Background

Primary Academic Title

Instructor, Department of Medicine/Hematology, WashU Medicine

Training

  • 2020 - 2023: Postdoctoral Fellow, Washington University, St. Louis, MO
  • 2023 - 2024: Staff Scientist, Washington University, St. Louis, MO

Education

  • 2014: MB, Sun Yat-sen University, Guangzhou, Guangdong, China
  • 2020: PhD, University South Florida, Tampa, FL

Research & Selected Publications

Research Interest

Myeloid Malignancies

Research Publications

A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies.
Authors:

He F, Lin S, Gao B, one or more additional authors omitted Oh ST

Journal & Year:

Cell Commun Signal • 2025

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
Authors:

Kong T, Laranjeira ABA, Letson CT, one or more additional authors omitted He F, one or more additional authors omitted Oh ST

Journal & Year:

Nat Commun • 2025

RSK1 dependency in FLT3-ITD acute myeloid leukemia.
Authors:

Kong T, Laranjeira ABA, Letson CT, one or more additional authors omitted He F, one or more additional authors omitted Oh ST

Journal & Year:

Blood Cancer J • 2024

Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms.
Authors:

He F, Laranjeira AB, Kong T, one or more additional authors omitted Oh ST

Journal & Year:

J Clin Invest • 2024